-
-
-
-
-
-
-
Equillium Announces Up to $50 Million Financing to Advance EQ504, a Novel Aryl Hydrocarbon Receptor Modulator, into the Clinic
-
-
-
-
-
-
-
Equillium (EQ) to Offer Common Stock
-
-
-
71,086 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

